Richard Brady, Ph.D.

Richard Brady has expertise in microeconomics and financial analysis. His experience includes high-stakes litigation matters involving life sciences, biotechnology, consumer technology, pharmaceuticals, telecommunications, semiconductor, software-as-a-service (SaaS), music, tobacco, and tech industries, among others.

Dr. Brady has taken the lead on several matters at the International Trade Commission and in several high-profile cases in U.S. District Courts. Notably, he managed work on the Juno Therapeutics v. Kite Pharma matter from the pre-litigation phase through trial completion. He was instrumental in helping secure a full damages award for Juno Therapeutics. Dr. Brady has also provided strategic licensing guidance to companies with foundational patent portfolios.

Known for his responsiveness to client requests, Dr. Brady is sought for his ability to deliver thorough and detailed analyses under tight deadlines, even delivering substantive work product within 24 hours when needed. According to Intellectual Asset Management (IAM), Dr. Brady “has a remarkable ability to digest and synthesize complicated records” and “is a driving force in developing damages theories [and] in preparing the lengthy and detailed expert reports necessary for complex cases.” IAM added that Dr. Brady’s “skill, intelligence, work ethic and tenacity make him indispensable.” Clients have described Dr. Brady as “having a commitment to excellence” and commented that it “is great working with him.”

Dr. Brady has applied his expertise and consulting expertise on economic issues on relating to intellectual property disputes, financial matters, contract and commercial disputes, licensing issues, and antitrust and competition.

His experience includes:

• Lost profits
• Reasonable royalties
• Economic domestic industry
• Unjust enrichment
• Competition
• Music copyright and trademark valuation
• Public interest analysis
• Commercial success
• Prejudgment interest
• Injunctive relief
• Bond analysis
• Market definition
• Irreparable harm
• Breach of contract
• Loss in company value

IAM recognized Dr. Brady as a top U.S. economic expert and rising star in 2020, 2021, 2022, and 2023.

Dr. Brady has published economic research in several peer-reviewed academic journals – including Econometrica, Social Choice and Welfare, Games and Economic Behavior, and Judgement and Decision Making.

Dr. Brady earned his Ph.D. in Economics from the University of California, San Diego, his M.A. in Economics from Duke University, his M.S. in Finance from the University of Memphis, and his B.S. in Finance and Management from Christian Brothers University.